The survival benefit of para-aortic lymphadenectomy in patients with LVSI-positive and grade 3 endometrioid carcinoma might be attributable to the inclusion of a subgroup with particularly poor prognosis, such as those harboring p53 mutations. Here, TP53 is linked to endometrioid adenocarcinoma.